Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy

Abstract

How the presence of inflammation has repercussions for brain function is a topic of active research into depression. Signals released from immune system-related cells, including chemokines, might be indicative of active depression and can, hypothetically, serve as biomarkers of response to interventions, both pharmacological and psychological. The objective of this study is to analyze the peripheral plasma concentrations of CXCL12, CCL11, CX3CL1 and CCL2 in a cohort of depressed primary-care patients, as well as their evolution after an internet-based cognitive-behavioral intervention. The concentrations of those chemokines were measured in 66 primary-care patients with mild and moderate depression, before and after the intervention, as well as 60 controls, using multiplex immunoassays. Concentrations of CXCL12 and CCL2 were significantly higher in the clinical sample in comparison with controls. A stable multivariate discriminative model between both groups was found. Concentrations of all chemokines decreased after the internet-based psychological intervention. These findings support the implication of chemokines in depression, even in a sample of patients with mild and moderate severity. Furthermore, they demonstrate the need for further multidisciplinary research that confirms how biomarkers such as plasma chemokines can serve as a marker for depression and are sensitive to non-pharmacological interventions. Depression is one of the most prevalent mental health problems throughout the world. In the last decade, it has been identified by the World Health Organization as one of the leading causes of disability worldwide 1,2. Despite extensive empirical support for the effectiveness of both psychological and pharmacological interventions 3,4 ,

Fractalkine, sICAM-1 and Kynurenine Pathway in Restrictive Anorexia Nervosa–Exploratory Study

“…Increased level of fractalkine may, therefore, constitute an independent factor associated with restrictive type of AN. Such conclusion corresponds with the data indicating that higher serum fractalkine is linked with an augmented sensitivity towards stressful stimuli and may negatively affect the mood [ 16 , 52 , 53 ]. A relatively low sensitivity of fractalkine assay used here is a limitation of the study; however, we were able to detect the compound in all but three patients’ samples.…”

The cognitive and psychiatric subacute impairment in severe Covid-19

“…Psychiatric symptoms might be related to viral-induced neuroinflammation. In this regard, persisting changes in chemokines have been detected in both, mild depression 41 and convalescent Covid patients 42 . Finally, decreased quality of life was reported by 57% of these patients 37 .…”

On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?

“…Moreover, several clinical studies found correlations between elevated levels of circulating inflammatory chemokines and depressive symptoms in patients with major depressive disorder [73,[80][81][82][83]. According to the results of a comprehensive meta-analysis, peripheral concentrations of a number of chemokines including CCL2, CCL3, CCL4, CCL11, CXCL4, CXCL7, and CXCL8 can potentially discriminate between individuals with depression and those without [84].…”